Table 3.
Outcome | Time | Mean | 95% CI |
---|---|---|---|
GerdQ test | Baseline | 1.34 | −0.42–3.09 |
Post 1 Week | 0.15 | −1.46–1.763 | |
Difference Post 1 Week - Baseline | 1.49 | 0.47–2.49 | |
PPT | Baseline | 0.56 | −5.03–6.15 |
Post-1st Treatment | 0.11 | −5.67–5.90 | |
Follow-up | 4.69 | −3.75–13.14 | |
Post-2nd Treatment | 8.22 | −1.08–17.53 | |
Difference Post 2nd Treatment - Baseline | 8.78 | 0.48–17.09 | |
Cervical mobility | Baseline | 2.49 | −28.55–33.54 |
Post-1st Treatment | 19.96 | −8.34–48.27 | |
Follow-up | 27.76 | −1.09–56.61 | |
Post-2nd Treatment | 31.39 | 1.77–61.02 | |
Difference Post 2nd Treatment - Baseline | 33.89 | 15.17–52.61 |
PPT, Pressure pain threshold; CI, confidence interval; Post-1st Treatment, after first intervention; Follow-up, after a week; Post-2nd Treatment, after second intervention.